NRC Health (NRC): EPS (Basic)
$50.00
Year ended 2025-12-31
+239.3%
3-year compound annual growth
+102.2%
5-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $50.00 | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $1.05 | -16.7% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $1.26 | -1.6% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $1.28 | -12.9% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $1.47 | -0.7% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $1.48 | +13.8% | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | $1.30 | n/a | 2022-03-04, From 2019-01-01 |
| No annual figure between 2012-12-31 and 2019-12-31. | |||
| 2012-12-31 | $2.22 | +28.3% | 2013-03-01, From 2012-01-01 |
| 2011-12-31 | $1.73 | +35.2% | 2013-03-01, From 2011-01-01 |
| 2010-12-31 | $1.28 | 0.0% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $1.28 | n/a | 2012-03-01, From 2009-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| NRC Health (NRC) | 2025-12-31 | $50.00 | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$0.42 | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$0.57 | n/m |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $15.64 | +19.8% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$8.66 | n/m |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$2.91 | n/m |
| Incyte Corp (INCY) | 2025-12-31 | $6.59 | n/m |
| Absci Corp (ABSI) | 2025-12-31 | -$0.84 | n/m |
| Icon PLC (ICLR) | 2025-12-31 | $2.92 | -67.4% |
Compare NRC, MXCT, OABI, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗